Orchestra BioMed Holdings, Inc. (OBIO) Profit Margins
Over the twelve months to 2026-06-30, Orchestra BioMed Holdings, Inc. (OBIO) had operating margin -181.4%, net margin -184.6%, free cash flow margin -184.8%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
OBIOOrchestra BioMed Holdings, Inc.Follow OBIO — free
—
Price chart with a free account
- Market cap
- 336.0M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|
| Gross margin | 93.3% | 92.3% | 99.4% | — | |
| Operating margin | -1866.2% | -2437.5% | -154.7% | -181.4% | |
| Net margin | -1779.7% | -2313.3% | -157.4% | -184.6% | |
| FCF margin | -1674.1% | -1927.5% | -147.7% | -184.8% |
USD millions · SEC XBRL
Orchestra BioMed Holdings, Inc. — questions
- What is Orchestra BioMed Holdings, Inc.'s operating margin?
- -181.4% over the twelve months to 2026-06-30.
- What is Orchestra BioMed Holdings, Inc.'s net profit margin?
- -184.6% over the twelve months to 2026-06-30.
Every figure on this page comes from Orchestra BioMed Holdings, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.